During "a House subcommittee hearing, Kennedy called even the programs with the finest reputations 'losers' because they treat people away from their communities and lack a consistent way of tracking behavior and keeping patients 'on the wagon' when they get back home." Kennedy "also dismissed as misplaced an entreaty by witness Nora D. Volkow, director of the National Institute on Drug Abuse, that incentives be created for pharmaceutical companies to develop treatments to counter addiction."